BridgeBio Pharma (BBIO) Operating Margin (2019 - 2026)
BridgeBio Pharma (BBIO) reported Operating Margin of 54.47% for Q1 2026, up 3502.0% on a YoY basis from 1.51% in Q1 2025, and up 39.82% sequentially from 90.52% in Q4 2025.
BridgeBio Pharma (BBIO) Operating Margin (2019 - 2026) Analysis & Trends
BridgeBio Pharma (BBIO) has 8 years of Operating Margin data on file, last reported at 54.47% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin rose 3502.0% year-over-year to 54.47%; the trailing twelve-month figure through Mar 2026 stood at 90.52% (up 45705.0% YoY), and the FY2025 full-year result was 104.25%, up 16297.0% from the prior year.
- Operating Margin rose to 54.47% in Q1 2026, from 90.52% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 0.16% in Q1 2024 to a low of 38200.0% in Q3 2022.
- A 5-year average of 6161.19% and a median of 3854.61% in 2023 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin plunged 3182206 bps in 2022 and jumped 3434539 bps in 2023, its largest moves.
- Tracing BBIO's Operating Margin over 5 years: stood at 6910.8% in 2022, then tumbled by 47 bps to 10167.11% in 2023, then jumped by 62 bps to 3842.69% in 2024, then surged by 98 bps to 90.52% in 2025, then surged by 40 bps to 54.47% in 2026.
- Business Quant data shows BBIO's Operating Margin at 54.47% in Q1 2026, 90.52% in Q4 2025, and 120.3% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn | -54.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54.47% |
| Dec 31, 2025 | -90.52% |
| Sep 30, 2025 | -120.30% |
| Jun 30, 2025 | -121.45% |
| Mar 31, 2025 | -89.49% |
| Dec 31, 2024 | -3,842.69% |
| Sep 30, 2024 | -7,018.67% |
| Jun 30, 2024 | -8,096.82% |
| Mar 31, 2024 | 0.16% |
| Dec 31, 2023 | -10,167.11% |
| Sep 30, 2023 | -3,854.61% |
| Jun 30, 2023 | -8,903.05% |
| Mar 31, 2023 | -6,909.26% |
| Dec 31, 2022 | -6,910.80% |
| Sep 30, 2022 | -38,200.00% |
| Jun 30, 2022 | -108.72% |
| Mar 31, 2022 | -10,252.54% |
| Dec 31, 2021 | -1,656.14% |
| Sep 30, 2021 | -6,377.94% |
| Jun 30, 2021 | -174.02% |